Canagliflozin: A review with specific focus on analytical methods in biological matrices and pharmaceuticals
Abstract: Sodium-glucose transporter 2 inhibitor emerges as the latest group of oral hypoglycemic agents, which shows insulin-independent pathology and provides an upper hand to enhance renal glucose elimination. Canagliflozin (CGN) was the number one drug, approved by FDA on 29th March 2013 for the treatment of type 2 diabetes mellitus. By totting up to its glucose-lowering effects, it exhibits beneficial effects on the heart and potentially on the kidneys. The study aims to summarize various analytical techniques, such as chromatography, spectrophotometry, and hyphenated techniques, such as Liquid chromatography with tandem mass spectrometry (LC-MS/MS) and Ultra performance liquid chromatography with tandem mass spectrometer (UPLC-MS) for the analysis of CGN. In the proposed work, we have reviewed various analytical methods reported for the estimation of CGN in biological matrices and Pharmaceuticals from various databases like ScienceDirect, Springer, PubMed, Scopus, Taylor & Francis, and Web of Science for the estimation of CGN. Various analytical methods adapted were high-performance liquid chromatography, UPLC, LC-MS/MS, high-performance thin-layer liquid chromatography, Fourier-transform infrared spectroscopy, spectrofluorimetry, and UV spectrophotometry. This current review presented the determination of CGN using various analytical techniques and biological matrices either in single or in combination with other hypoglycemic agents, as per International Conference on Harmonization guidelines. Further, some future trends that can be integrated were also suggested.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Canagliflozin: A review with specific focus on analytical methods in biological matrices and pharmaceuticals ; volume:41 ; number:1 ; year:2022 ; pages:287-300 ; extent:14
Reviews in analytical chemistry ; 41, Heft 1 (2022), 287-300 (gesamt 14)
- Urheber
-
Azhakesan, Ajitha
Kuppusamy, Sujatha
- DOI
-
10.1515/revac-2022-0049
- URN
-
urn:nbn:de:101:1-2022120713241314902718
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Azhakesan, Ajitha
- Kuppusamy, Sujatha
Ähnliche Objekte (12)
Analytical applications of electrode sensitive to labetalol in pharmaceuticals
Analytical methods to study the degradation of iodine-containing pharmaceuticals
Strategies for the quantification of pharmaceuticals in biological samples
Multimodal imaging and speciation analysis of pharmaceuticals in biological tissues
Analytical chemistry of complex matrices
Analytical tools for determination of new oral antidiabetic drugs, glitazones, gliptins, gliflozins and glinides, in bulk materials, pharmaceuticals and biological samples
Focus on analytical methodologies for space exploration
Method development for the quantification of pharmaceuticals in aqueous environmental matrices
Chromatographic, electrophoretic and spectrometric analytical methods to characterize lead structures, pharmaceuticals and biopharmaceuticals
Pre-Analytical, Analytical and Biological Sources of Variation of Lipoprotein(a)
Pharmaceuticals in the aquatic environment and their elimination by innovative biological processes
Biological matrices and tissue reconstruction
Analytical applications of electrode sensitive to labetalol in pharmaceuticals
Analytical methods to study the degradation of iodine-containing pharmaceuticals
Strategies for the quantification of pharmaceuticals in biological samples
Multimodal imaging and speciation analysis of pharmaceuticals in biological tissues
Analytical chemistry of complex matrices
Analytical tools for determination of new oral antidiabetic drugs, glitazones, gliptins, gliflozins and glinides, in bulk materials, pharmaceuticals and biological samples
Focus on analytical methodologies for space exploration
Method development for the quantification of pharmaceuticals in aqueous environmental matrices
Chromatographic, electrophoretic and spectrometric analytical methods to characterize lead structures, pharmaceuticals and biopharmaceuticals
Pre-Analytical, Analytical and Biological Sources of Variation of Lipoprotein(a)
Pharmaceuticals in the aquatic environment and their elimination by innovative biological processes
Biological matrices and tissue reconstruction
Analytical applications of electrode sensitive to labetalol in pharmaceuticals
Analytical methods to study the degradation of iodine-containing pharmaceuticals
Strategies for the quantification of pharmaceuticals in biological samples
Multimodal imaging and speciation analysis of pharmaceuticals in biological tissues
Analytical chemistry of complex matrices
Analytical tools for determination of new oral antidiabetic drugs, glitazones, gliptins, gliflozins and glinides, in bulk materials, pharmaceuticals and biological samples
Focus on analytical methodologies for space exploration
Method development for the quantification of pharmaceuticals in aqueous environmental matrices
Chromatographic, electrophoretic and spectrometric analytical methods to characterize lead structures, pharmaceuticals and biopharmaceuticals
Pre-Analytical, Analytical and Biological Sources of Variation of Lipoprotein(a)
Pharmaceuticals in the aquatic environment and their elimination by innovative biological processes